Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shiwei Yiyuan is a traditional Chinese medicine (TCM) formulation, most commonly encountered as "Shiwei Yiyuan granules." It is used in the context of integrative cancer therapy and has been studied for its potential to improve quality of life in cancer patients, particularly those undergoing chemotherapy or radiotherapy. The precise herbal composition and mechanism of action are not specified in the available sources. However, as a TCM product, it likely contains a combination of herbal ingredients traditionally believed to support immune function and alleviate symptoms associated with cancer treatment. There is at least one clinical trial investigating its use for supportive care in oncology settings[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shiwei Yiyuan.